Immunome, Inc.
IMNM
$20.86
$0.150.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -69.90M | -57.46M | -43.40M | -41.64M | -80.25M |
| Total Depreciation and Amortization | 776.00K | 733.00K | 720.00K | 726.00K | 595.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 17.95M | 5.88M | 5.03M | 4.89M | 32.31M |
| Change in Net Operating Assets | 3.22M | 10.33M | -11.76M | -17.03M | 5.29M |
| Cash from Operations | -47.95M | -40.51M | -49.40M | -53.06M | -42.06M |
| Capital Expenditure | -4.00M | -1.12M | -905.00K | -3.67M | -1.13M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 125.00M | -63.27M | 8.75M | 10.88M |
| Cash from Investing | -4.00M | 123.88M | -64.17M | 5.09M | 9.76M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 460.58M | 46.31M | 215.00K | 172.71M | 20.49M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -27.78M | -919.00K | -270.00K | -10.49M | -400.00K |
| Cash from Financing | 432.80M | 45.39M | -55.00K | 162.23M | 20.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 380.84M | 128.76M | -113.63M | 114.26M | -12.22M |